Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
Has anyone ever considered the prospect of us being cash flow neutral/positive.
We have been informed that sales are the "fuel" of the business and that customer retention over a two year period is 100%
So with new better platforms and customers coming on board and grants for the cancer study, plus the cash in hand at the end of 2021 we could well be in a position where no new finance is required
Just a thought
Many thanks to JHFH and HFH for taking the time and effort to educate and help rally the troops over what has been a very taxing few years. Whilst I did not take your comments as investment advice it most definately aided my decision to add at the lows to significantly reduce my average to under 2p.
I am sorry that you have had to endure barbs from newly arrived investors with agendas for just trying to inform and hope that this will not deter you in the future, unfortunately all boards like this are infested with idiots once a rise in price begins.
If you do not even know on what market your shares are traded and what this means in relation to large institutional investor participation then you should be banned from holding shares.
Apologies if already posted
Article from WSJ
https://www.wsj.com/articles/hemogenyx-pharmaceuticals-plc-announces-single-cbr-can-treat-multiple-viruses-01673247940
The RSI can also drop when a share is consolidating within a range.
Due to the possibility of news within 2/3 weeks this is more likely to range between 2.3 and 2.5 as any drop below will be seen as a buying opportunity.